Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
Add more filters










Publication year range
1.
Int Urol Nephrol ; 38(3-4): 811-3, 2006.
Article in English | MEDLINE | ID: mdl-17160447

ABSTRACT

Anaemia is a common finding in elderly patients particularly in those with chronic kidney disease. Effective correction of anaemia improves survival and quality of life. The association between anaemia and a poor nutritional status as well as the presence of inflammation has already been documented. The aim of our study was to assess the impact of the nutritional and inflammatory status on darbepoetin dose requirements of elderly patients followed in a "Chronic Kidney Disease" outpatient clinic. We included 71 elderly patients (age>or=65 years) in a "Chronic Kidney Disease" outpatient clinic. Creatinine Clearance (CrCl) was estimated according to the Cockroft-Gault equation. Nutritional status was evaluated by biochemical and anthropometric parameters. Tumour Necrosis Factor-alpha (TNF-alpha), Interleukin-6 (IL-6) and high sensitivity C-reactive protein (hs-CRP) were used as biomarkers of inflammation. Our patients (56% males) with a mean age of 76.2+/-6.6 years were followed for 33.1+/-43.6 months. Mean eCrCl was 13.5+/-7.2 ml/mn/1.73 m2. All patients were under supplemental iron therapy and 74.7% needed darbepoietin (0.762+/-0.6 (microg/kg/week) to correct anaemia. Among the several variables regressed on darbepoietin dose, in a multiple regression model, only Hb, IL-6 and TNF-alpha levels and SGA score predicted the need for higher doses of darbepoietin. (r=0.677; r2=0.459). In Conclusion, in our pre-dialysis elderly patients, markers of a poor nutritional status (SGA and albumin) and inflammation (IL-6 and TNF-alpha) independently predicted the use of higher doses of darbepoietin to correct anaemia.


Subject(s)
Erythropoietin/analogs & derivatives , Hematinics/administration & dosage , Inflammation , Nutritional Status/drug effects , Aged , Aged, 80 and over , Darbepoetin alfa , Erythropoietin/administration & dosage , Female , Humans , Male , Renal Dialysis
2.
Am J Kidney Dis ; 30(2): 224-8, 1997 Aug.
Article in English | MEDLINE | ID: mdl-9261033

ABSTRACT

In the past few years in Western countries, there has been an increasing proportion of elderly patients beginning renal replacement therapy. Left ventricular hypertrophy (LVH) is associated with an increased mortality rate due to cardiovascular disease, the main cause of death in patients on chronic hemodialysis. In this study, we evaluated 67 chronic hemodialysis patients older than 65 years (33 women and 34 men; mean age, 72.6 years; mean time on chronic hemodialysis, 51.3 months). Several biological and laboratory data were analyzed. The left ventricular mass was calculated using the Penn convention criteria. LVH was observed in 49 patients (73%). These 49 patients were divided into two groups (group 1, concentric hypertrophy, n = 22; and group 2, eccentric hypertrophy, n = 27) and compared with a control group (patients without LVH, n = 18). Group 1 (P = 0.06) and group 2 (P = 0.055) showed higher systolic blood pressures and group 2 showed a lower hematocrit (P = 0.024). The echocardiographic parameters were expectedly different: group 1 had higher posterior left ventricular wall thickness (P = 0.0001), interventricular septum thickness (P = 0.0001), and left ventricular wall relative thickness (P = 0.002), and group 2 had higher left ventricular end-diastolic diameter (P = 0.0001), interventricular septum thickness (P = 0.01), and posterior left ventricular wall thickness (P = 0.023). Using the left ventricular mass index as the dependent variable and the evaluated biological and laboratory data as the independent variables, we found in a stepwise multiple regression model that only systolic blood pressure (t = 3.430; P = 0.0011), age (t = 2.059; P = 0.044), interdialytic weight gain (t = 2.236; P = 0.029), and hematocrit (t = -1.961; P = 0.054) independently influenced the left ventricular mass index (R2 = 0.313; P = 0.0001). Further studies are needed to determine whether reduction of the left ventricular mass index, through control of blood pressure and correction of anemia, will decrease the cardiovascular events in this particular population.


Subject(s)
Hypertrophy, Left Ventricular/etiology , Renal Dialysis/adverse effects , Age Factors , Aged , Aged, 80 and over , Blood Pressure , Echocardiography , Female , Hematocrit , Humans , Hypertrophy, Left Ventricular/diagnostic imaging , Hypertrophy, Left Ventricular/physiopathology , Male , Regression Analysis , Risk Factors
3.
Kidney Int Suppl ; 55: S160-2, 1996 Jun.
Article in English | MEDLINE | ID: mdl-8743543

ABSTRACT

Left ventricular hypertrophy (LVH) is associated with an increase in cardiovascular death in essential hypertension (EH). The factors involved in LVH are multiple and complex. We looked for risk factors of LVH in a group of 28 nonobese patients with EH (mean age = 45.3 years). We analyzed the activity of several erythrocyte ion transports (Vmax of NaLi countertransport, NaKCl cotransport and NaK-pump, and the Na-leak Kp Na), the intracellular Na and the insulin sensitivity index. All these parameters were used as independent variables whereas the left ventricular mass index (LVMI) was used as the dependent variable. Variables showing a significant univariate correlation (age, time of EH, mean blood pressure and Vmax of NaLi countertransport) were introduced in a stepwise multiple regression model. Only age (P = 0.014), time of EH (P = 0.038) and Vmax of NaLi countertransport (P = 0.032) were independently associated with LVMI (R2 = 0.581, P = 0.0001). The NaLi CT, an operating mode of the NaH exchanger that facilitates cellular growth, may be a marker of LVH, and consequently a marker of increased cardiovascular risk.


Subject(s)
Antiporters/blood , Hypertension/physiopathology , Hypertrophy, Left Ventricular/physiopathology , Adult , Erythrocytes/metabolism , Female , Humans , Hypertension/epidemiology , Hypertension/metabolism , Hypertrophy, Left Ventricular/epidemiology , Hypertrophy, Left Ventricular/metabolism , Kinetics , Lipids/blood , Male , Middle Aged , Risk Factors , Sodium/blood
6.
Age Ageing ; 23(5): 356-9, 1994 Sep.
Article in English | MEDLINE | ID: mdl-7825479

ABSTRACT

There is in the Western World a progressive ageing of the population, and consequently haemodialysis patients are also getting older. Some ethical questions have been raised as a consequence of the economic issues related to the scarcity of available resources. In this paper we review our experience in the treatment of very old chronic haemodialysis patients. Fifty patients (7.2% of our haemodialysis patients) aged over 80 years at the beginning of dialysis were included (f = 25, m = 26, age = 82.6 +/- 0.3 years). In 42% of the patients the aetiology of renal disease was unknown. In the remainder, the aetiology was: interstitial nephritis 26%, hypertensive nephrosclerosis 14%, chronic glomerulonephritis 8%, diabetes 8% and polycystic disease 2%. There was a great comorbidity: intradialytic hypotension 82%, cardiac disease 74%, gastrointestinal disease 32%, cerebrovascular disease 26%. Vascular access related problems were the main reason for hospitalization. The major cause of death was vascular (cardiac and cerebral disease). Actuarial survival was 89%, 78%, 56% and 48% at 6, 12, 24 and 36 months, respectively. We think that haemodialysis is the best available choice for treating very old chronic renal failure patients. However further studies are needed to improve the quality of life of these patients.


Subject(s)
Kidney Failure, Chronic/therapy , Renal Dialysis , Aged , Aged, 80 and over , Cost Control/trends , Female , Health Care Rationing/economics , Humans , Kidney Failure, Chronic/economics , Kidney Failure, Chronic/etiology , Male , Portugal , Quality of Life , Renal Dialysis/economics , Treatment Outcome
10.
Acta Med Port ; 5(1): 11-3, 1992 Jan.
Article in Portuguese | MEDLINE | ID: mdl-1570746

ABSTRACT

During the last years there has a significant increase of elderly patients included in chronic dialysis programs. No agreement has been reached about the preferable treatment modality. In this study we analyse our experience in the management of patients over 70 years of age undergoing chronic acetate hemodialysis (HDCA). Sixty four of those patients have initiated HDCA between May 1982 and December 1990 (Mean age 75.9 +/- 4.8). The etiology of renal disease was unknown in a significant number of cases. Morbility was largely due to vascular disease (both cardiac and cerebral). Main causes of death were also vascular disease and infections. Actuarial survival was 79.6% at 12 months and 46.3% after 5 years. Although HDCA is associated with a greater morbility it is the most widely used modality of treatment for chronic renal failure in Portugal and in our experience, it is an acceptable method for elderly patients.


Subject(s)
Acetates/administration & dosage , Kidney Diseases/therapy , Renal Dialysis , Aged , Aged, 80 and over , Female , Humans , Kidney Diseases/complications , Male , Time Factors
11.
Acta Med Port ; 3(4): 205-7, 1990.
Article in Portuguese | MEDLINE | ID: mdl-2275411

ABSTRACT

Haemodialysis is the most used among the different renal function replacement methods. Although the survival is acceptable the mobility is important; intradialytic hypotension is a main cause of such mobility. In this study which included stable chronic haemodialysis patients, the authors evaluate risk factors for IDH. Advanced age, female sex and autonomic insufficiency are risk factors for IDH. Patients with IDH had more serious ventricular arrhythmias, but a cause-effect relationship was not demonstrated.


Subject(s)
Hypotension/etiology , Renal Dialysis/adverse effects , Aged , Bicarbonates/blood , Female , Humans , Hypotension/blood , Hypotension/complications , Male , Middle Aged , Risk Factors
13.
Acta Med Port ; 2(4-5): 199-201, 1989.
Article in Portuguese | MEDLINE | ID: mdl-2618807

ABSTRACT

29 pregnancies in 27 renal patients were reviewed. The etiology of renal disease was mainly glomerular (14 patients). At the beginning of pregnancy 11 patients had renal failure and 14 patients had a high blood pressure. Only two patients had pregnancy related worsening of the renal function (the two patients had a normal renal function before pregnancy). Maternal morbidity was infrequent with no mortality. Fetal loss was 21.5% related to prematurity. There were no congenital anomalies. Renal failure at the beginning of pregnancy caused an obstetric risk factor. (greater fetal prematurity and mortality).


Subject(s)
Hypertension/physiopathology , Kidney Diseases/physiopathology , Pregnancy Complications/physiopathology , Adult , Female , Humans , Pregnancy , Retrospective Studies , Urology Department, Hospital
SELECTION OF CITATIONS
SEARCH DETAIL
...